BioSpace - Financial Content

Symbol 'BPA' could not be found. Search For:

Fri, May 15, 2009
	Blue Parrot Energy Inc. Shareholder Approval of Common Share Consolidation and Name Change to Ria Resources Corp. - CCN
Mon, Apr 20, 2009
	Blue Parrot Energy Inc. Announces Asset Acquisition - CCN
Fri, Mar 27, 2009
	Blue Parrot Energy Inc. Announces Asset Acquisition, Flow-Through Placement, Change of Auditor and AGM Matters - CCN
Fri, Dec 21, 2007
	Blue Parrot Energy Closes Private Placement Financings - CCN
Tue, Nov 27, 2007
	NYSSA Presents 11th Annual Biotech/Specialty Pharma Conference - Business Wire
More Press Releases

Tue, Sep 11, 2007
	BioSante Pharmaceuticals (BPA) received clarity from and is in agreement with FDA Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2942047 for the full story. - StreetInsider
Wed, Jun 13, 2007
	Bradley Pharmaceuticals (BDY) Announces Launch of Elestrin Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2472203 for the full story. - StreetInsider
Fri, May 25, 2007
	BioSante Pharmaceuticals (BPA) Announces $16.5 Million Private Placement of Common Stock Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2357769 for the full story. - StreetInsider
More News

Tue, Jul 10, 2007
	BioSante Pharmaceuticals, Inc. (BPA) BioSante Pharmaceuticals, Inc. (BPA) Rich Hancock welcomes back Mr. Stephen M. Simes, CEO of BioSante Pharmaceuticals Inc. BioSante is developing a pipeline of hormone therapy products to treat both men and women. Listen to the podcast to hear the latest from BioSante. Leave Comment Related Entries: BioSante Pharmaceuticals Inc. to Appear on MN1.com Microfluids Lead to Macroprofits BioForce Nanosciences Holdings, Inc. (BFNH) Ener1 Inc. (ENEI) video BioForce Nanosciences Holdings, Inc. (BFNH) Video BioSante Pharmaceuticals, Inc. (BPA) BioForce Nanosciences Holdings, Inc. (BFNH) BioSante - THE BIG REVEAL Enable IPC Corp (EIPC) BioForce Nanosciences Talks Live With the MN1 News Team - MN1
Wed, Jun 06, 2007
	BioSante Pharmaceuticals, Inc. (BPA) BioSante Pharmaceuticals, Inc. (BPA) BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver bio-identical estradiol and testosterone. BioSante's lead products include Elestrin (estradiol gel), developed through U.S. Food and Drug Administration (FDA) approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, and LibiGel (transdermal testosterone gel) in Phase III development for the treatment of female sexual dysfunction (FSD). The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including hepatitis B, avian flu and biodefense vaccines for toxins such as anthrax, as well as a system for delivering drugs via alternative routes of administration. CEO Stephen Simes discusses the company's recent developments and future plans and a new oral contraceptive license agreement with Kate Delaney. Listen to learn more. Leave Comment Related Entries: BioForce Nanosciences Holdings, Inc. (BFNH) BioSante - THE BIG REVEAL Enable IPC Corp (EIPC) BioForce Nanosciences Talks Live With the MN1 News Team Enable IPC Corp. CEO David Walker Will Discuss Company's Technologies Live on MN1.com - MN1
Tue, Dec 05, 2006
	BioSante Pharmaceuticals, Inc. Small-Cap Discovery Conference - VCall Podcasts
Tue, Jul 25, 2006
	Wall Street Reporter: BioSante Pharmaceuticals, Inc. BioSante Pharmaceuticals, Inc. - Wall Street Repor...
Thu, Jun 29, 2006
	Wall Street to Main Street: News, Views and Commentary: June 29, 2006 Time Warner, Microsoft, Apple Computer, Playboy Enterprises, Nike, Nanophase Technologies - NAMC Radio
More Podcasts

11/05/07		Special Conference BioSante Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference Archive for BPA
10/10/07		Special Conference BIOSANTE PHARMACEUTICALS INC at Biotechnology Industry Organization Investor Forum Archive for BPA
10/04/07		Special Conference BioSante Pharmaceuticals to Present at The Think Equity Partners Annual Growth Conference Archive for BPA
09/18/07		Special Conference InformedInvestors.com Presentation Archive for BPA
09/11/07		Business News Clinical Development Update Archive for BPA

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs